Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $125.00 | 1 | 60.3% |
| Food and Beverage | $82.18 | 4 | 39.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $137.83 | 2 | $0 (2023) |
| Alkermes, Inc. | $41.94 | 2 | $0 (2022) |
| ABBVIE INC. | $27.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.41 | 1 | ABBVIE INC. ($27.41) |
| 2023 | $12.83 | 1 | Indivior Inc. ($12.83) |
| 2022 | $41.94 | 2 | Alkermes, Inc. ($41.94) |
| 2019 | $125.00 | 1 | Indivior Inc. ($125.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: OUD | ||||||
| 02/15/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: CNS | ||||||
| 01/13/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: CNS | ||||||
| 07/18/2019 | Indivior Inc. | SUBOXONE (Drug) | — | Cash or cash equivalent | $125.00 | Research |
| Study: Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information • Category: OUD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
About Dr. Jane Mccaffrey, MD
Dr. Jane Mccaffrey, MD is a Pediatrics healthcare provider based in Geneva, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235206962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Mccaffrey, MD has received a total of $207.18 in payments from pharmaceutical and medical device companies, with $27.41 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "" ($125.00).
Practice Information
- Specialty Pediatrics
- Location Geneva, NY
- Active Since 11/29/2006
- Last Updated 11/29/2011
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1235206962
Products in Payments
- SUBOXONE (Drug) $125.00
- ARISTADA (Drug) $41.94
- VRAYLAR (Drug) $27.41
- SUBLOCADE (Drug) $12.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Geneva
Diane Nielsen, M.d, M.D
Pediatrics — Payments: $2,212
Srisudha Gundala, M.d, M.D
Pediatrics — Payments: $1,520
Dr. Sissay Anberber, Md, MD
Pediatrics — Payments: $714.76
Mrs. Lisa Fitzgerald, Pnp, PNP
Pediatrics — Payments: $130.24
Kathrin Berg, Md, MD
Pediatrics — Payments: $98.21
Neelam Agarwal, M.d, M.D
Pediatrics — Payments: $58.51